Quantinno Capital Management’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$844K Sell
60,077
-54,639
-48% -$1.1M ﹤0.01% 2905
2026
Q2
$2.55M Buy
114,716
+84,165
+275% +$1.76M ﹤0.01% 1755
2026
Q1
$429K Buy
30,551
+1,059
+4% +$15.3K ﹤0.01% 2825
2025
Q4
$455K Buy
29,492
+2,517
+9% +$29.5K ﹤0.01% 2517
2025
Q3
$233K Buy
26,975
+4,989
+23% +$40.8K ﹤0.01% 2649
2025
Q2
$220K Buy
+21,986
New +$748K ﹤0.01% 2283

Other funds holding JBIO

Quantinno Capital Management's JBIO Position: Q3 2026 in Review

Quantinno Capital Management reduced its Jade Biosciences (JBIO) stake by 48% in Q3 2026, selling an estimated $1.1M and leaving 60,077 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #2905.

Quantinno Capital Management first reported a position in JBIO in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.55M in Q2 2026. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Quantinno Capital Management held 60,077 shares of Jade Biosciences worth $844K as of Q3 2026.
  • Quantinno Capital Management sold 54,639 Jade Biosciences shares in Q3 2026, an estimated $1.1M.
  • Jade Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2905 holding.
  • Quantinno Capital Management first reported a position in Jade Biosciences in Q2 2025 and has held it in 6 quarters since.
  • Quantinno Capital Management's Jade Biosciences position peaked at $2.55M in Q2 2026.
  • 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.